Results

General Characteristics
As shown in Table 1 , there was no significant difference in age, BMI, waist circumference, and blood pressure between the CAD and non-CAD groups. Most patients in the CAD group were men (86%) and had a high prevalence of metabolic syndrome, triglyceride levels ≥150 mg/dL (1.69 mmol/L), highdensity lipoprotein (HDL) cholesterol levels <40 mg/dL (1.04 mmol/L), low-density lipoprotein (LDL) cholesterol levels ≥140 mg/dL (3.63 mmol/L) and statin use, and diabetes mellitus (52%). In the lipid profile, LDL-and HDL-cholesterol levels were significantly lower in the CAD group than in the non-CAD group (both P<0.001) presumably because of the higher frequency of dyslipidemia and statin use in the CAD group. Plasma glucose and glycosylated hemoglobin (HbA 1c ) were also higher in the CAD group. As shown in File I in the onlineonly Data Supplement, EATV and the EATV index were higher in the CAD group. Waist circumference and visceral fat area (VFA) were slightly higher in the CAD group, and BMI and subcutaneous fat area were comparable between the 2 groups.
Determinants of the EATV Index
By univariate logistic regression analysis, the EATV index was found correlated with age, body weight, BMI, waist circumference, VFA (cm 2 ), subcutaneous fat area (cm 2 ), systolic blood pressure (mm Hg), HbA 1C (National Glycohemoglobin Standardization Program, %), type 2 diabetes mellitus (%), HDL-cholesterol (mmol/L), triglycerides (mmol/L), triglycerides ≥1.69 (mmol/L), and HDL-cholesterol <1.04 (mmol/L), number of metabolic risk components (%), CAD (yes/no), and number of vessels with angiographically determined ≥75% stenosis (File II in the online-only Data Supplement). When the non-CAD and CAD groups were combined, the EATV index was found correlated with waist circumference, BMI, VFA, and subcutaneous fat area ( Figure 1 ). Three separate multiple regression analyses were performed on relationships to EATV index of combinations of possible determinants selected from the univariate logistic regression analysis (File II in the online-only Data Supplement): classical coronary risk factors were included in model 1, existence of CAD itself were added in model 2, and abdominal adiposity marker (VFA) were added in model 3 ( Table 2 ). The multivariate logistic regression analysis indicated that age, BMI, triglycerides ≥1.69 (mmol/L), and HDL-cholesterol <1.04 (mmol/L) were predictors in model 1. When CAD (model 2) and VFA (model 3) were included in the multivariate logistic regression analysis model, R 2 was increased to 0.254 and 0.286, respectively ( Table 2 ).
Correlations Between the EATV Index and Cytokine/Adipocytokine Expression
Next, we determined the correlations among the EATV index, number of macrophages, and pro-and anti-inflammatory cytokines/adipocytokines ( Table 3 and Figure 2 ). The EATV index was positively correlated with the numbers of CD68 + and CD11c + cells and the expression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3), IL-1β, and IL1RN in EAT. In contrast, the EATV index was negatively correlated with adiponectin expression ( Figure 2 ). When samples were subdivided into non-CAD and CAD groups, the number of CD68 + , CD11c + , and CD206 + cells, and the expression of NLRP3 and IL-1β were significantly higher and the expression of adiponectin was significantly lower in the CAD group ( Figure 3 ). In SCAT, the number of CD68 + cells and the expression of NLRP3 and IL-1β were comparable between the 2 groups, whereas the number of CD11c + cells was higher and the expression of adiponectin was lower in the CAD group. As shown in Figure 4 , the number of CD11c + cells and the expression of NLRP 3 and IL-1β were well correlated between EAT and SCAT. By immunohistochemical staining, CD68 + and NLRP3 signals were found to be colocalized in EAT (data not shown). Six separate multiple regression analyses were performed on relationships to existence of CAD of possible determinants selected from the univariate logistic regression analysis (File III in the online-only Data Supplement): classical coronary risk factors were included in model 1, EATV index were added in model 2, CD68, IL-1β, and adiponectin in EAT were added separately in model 3, 4, and 5, and combined in model 6 ( Table 4 ). Multivariate regression analysis indicated that the corrected R 2 was 0.383 in model 1, using common coronary risk factors, such as male sex (yes/no), age (years), VFA (cm 2 ), hypertension (yes/no), smoking (yes/no), diabetes mellitus (yes/no), low-density lipoprotein ≥3.63 (mmol/L) or statin use (yes/no), triglycerides ≥1.69 (mmol/L) or HDL <1.04 (mmol/L) (yes/no), and R 2 increased to 0.457 by the inclusion of the EATV index (model 2). Further, the number of CD68 + cells (model 3), expression of IL-1β (model 4), and expression of adiponectin (model 5) were included in this multivariate model, and R 2 increased to 0.631, 0.626, and 0.675, respectively (Table 4 ). When CD68 + cells, IL-1β, and adiponectin expression were together included in the model, the EATV index were no longer a predictor and R 2 increased up to 0.822.
Determinants of CAD
Discussion
The major findings in this study are as follows: First, we found that the EATV index is determined by male sex, VFA, and the existence of CAD, in the multivariate regression model. Second, we clarified that the EATV index was positively correlated with the number of CD68 + and CD11c + cells, and the expression of NLRP3, IL-1β, and IL1RN in EAT, but was negatively correlated with adiponectin expression. Finally, we showed that the number of CD68 + cells, the expression of IL-1β, and the expression of adiponectin were closely associated with the EATV index, and combinations of these 3 factors well explain the existence of CAD, suggesting that the EATV index is a strong determinant for CAD in combination with cytokine/adipocytokine imbalance, independent of overall adiposity.
Determinants of the EATV Index
We showed that the EATV index was determined by male sex, VFA, and the existence of CAD, in the multivariate regression model. In 1155 participants without cardiovascular disease from the Framingham Heart Study, Rosito et al 9 showed that epicardial fat volume was directly correlated with coronary risk factors, such as higher triglycerides, lower HDL-cholesterol, hypertension, diabetes mellitus, and the metabolic syndrome. They also showed that the associations persisted after additional adjustments for BMI and waist circumference, but not after adjustment for VAT. 9 Our results are consistent with their results. Our model 3 in Table 3 shows that the associations between the EATV index and coronary risk factors did not persist after adjustment for VFA and the existence of CAD. The present findings are consistent with previous reports showing that EATV is associated with angiographic CAD 8, 12, 13, 18 or with coronary calcification. 9 The associations between the existence of CAD and EATV suggest that CAD may exert local effects on the adiposity in EAT as discussed below. Expression levels in arbitrary unit. AMACC1 indicates alternative macrophage activation-associated CC chemokine-1; ARG-1, arginase-1; EAT, epicardial adipose tissue; EATV, epicardial adipose tissue volume; IL, interleukin; MCP-1, monocyte chemoattractant protein-1; NLRP3, nucleotide-binding domain, leucine-richcontaining family, pyrin domain-containing-3; RANTES, regulated upon activation, normal T-cell expressed and presumably secreted; SCAT, subcutaneous adipose tissue. TGF, transforming growth factor; and TNF, tumor necrosis factor.
Correlations Between the EATV Index and Cytokines/Adipocytokines
We clarified that the EATV index was positively correlated with the number of CD68 + and CD11c + cells and the expression of NLRP3, IL-1β, and IL1RN, but was negatively correlated with adiponectin expression. It has been reported that epicardial fat is associated with increased expression of inflammatory markers, including monocyte chemoattractant protein-1, IL-6, and tumor necrosis factor-α. [1] [2] [3] Our results showed that the EATV index was quantitatively associated with these inflammatory signals. The expression and secretion of adipocytokines in VAT and SCAT have been well documented in biopsies taken from lean healthy subjects, as compared with biopsies from obese healthy subjects. 19, 20 Other studies indicated that VAT and SCAT from obese subjects contain more macrophages, [22] [23] [24] tumor necrosis factor-α, IL-6, IL-8, IL-10, resistin, monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, angiotensinogen, vascular endothelial growth factor, and transforming growth factor-β, and less adiponectin and leptin than VAT and SCAT from lean subjects. [19] [20] [21] Like in VAT and SCAT, our study showed that macrophages and proinflammatory adipocytokines were upregulated, but the anti-inflammatory adipocytokine adiponectin was downregulated in EAT biopsies from CAD patients. The emergence of chronic inflammation, implied by factors such as tumor necrosis factor-α, IL-6, resistin, and monocyte chemoattractant protein-1 expression, has been reported as a possible mechanism for obesity-induced insulin resistance and atherosclerosis. [20] [21] [22] [23] [24] To the best of our knowledge, this is the first report to compare EATV with the number of macrophages and the expression of various cytokines/adipocytokines in EAT. Interestingly, EATV correlated strongly with NLRP3, IL-1β (and its receptor IL1R), and adiponectin, but not with other inflammatory signals. The NLRP3 inflammasome is a sensor in the nod-like receptor family of the innate immune cell system, and its activation leads to the maturation of caspase-1 and the processing of its substrate, IL-1β. 25 Because the NLRP3 inflammasome is a newly recognized candidate for obesity-associated metabolic disorders, 26, 27 the augmented expression of NLRP3, IL-1β, and IL1R might be linked to pathophysiological change in EAT. As shown in Figure 4 , the expression of NLRP and IL-1β was well correlated between EAT and SCAT, but was more intense in EAT, suggesting a local stimulation of this NLRP3 inflammasome signals in EAT. On the contrary, proinflammatory cytokines, such as tumor necrosis factor-α, IL-6, monocyte chemoattractant protein-1, transforming growth factor-β 1 , arginase-1, and alternative macrophage activation-associated CC chemokine-1, did not correlate with EATV. The factors differentiating more closely related proinflammatory cytokines with EAT and others are currently unknown. The underlying mechanisms should be clarified in future studies.
Determinants of CAD
We showed that the number of CD68 + cells and the expression of IL-1β and adiponectin were closely associated with the EATV index, and combinations of these 3 factors well explain the existence of CAD. Although previous studies reported that EATV is a significant determinant for CAD, associations with overall adiposity and cytokine/adipocytokine profiles in EAT has not been elucidated. Our findings indicate that the EATV index is a strong determinant for CAD in combination with cytokine/adipocytokine imbalance. Namely, the expression of IL-1β (an NLRP3 inflammasome-associated signal) and adiponectin (an antiinflammatory adipocytokine) might be balanced in combination with epicardial fat macrophage activity and may be linked to coronary atherosclerosis. Previously, we reported that infiltration of macrophages in EAT was enhanced in patients with CAD, 16, 17 and the polarization of M 1 /M 2 macrophages was shifted toward a proinflammatory state. 16 Collectively, epicardial fat, located near the coronary arteries, has a locally toxic effect on the vasculature, in combination with cytokine/adipocytokine imbalance. [1] [2] [3] [4] 
Limitations
This study has several limitations. First, our sample size is relatively small, and patient selection bias is likely present. Second, this study was based on 2 methods-counting of immunohistochemically stained macrophages in the adipose tissue and the use of real-time quantitative polymerase chain reaction to measure the expression of various cytokines. We concur that flow cytometry is more suitable for evaluating macrophage infiltration in EAT. However, on the basis of many previous studies, we believe that immunohistochemical analysis allows estimating macrophage numbers in adipose tissue. Third, the expression of cytokines was evaluated on whole tissue biopsy and thus it cannot be assumed that the findings represent only the production by inflammatory cells. Fourth, it is difficult to speculate whether the inflammatory response in the epicardial fat is the cause or the result of coronary atherosclerosis. Finally, we still cannot know whether the main pathogenic factor linked to CAD is EAT or overall adiposity. To clarify whether the amount of EAT is the primary cause of atherogenic CAD independently of abdominal obesity, or total visceral fatness, we may evaluate CAD mortality in patients who have a normal body weight and large amounts of EAT, a condition called cardiac obesity, as discussed by Chaowalit and Lopez-Jimenez. 28 
